文献速递甲状腺疾病

多基因评分与甲状腺乳头状癌肿瘤分子亚型的关联

Association of Polygenic Score With Tumor Molecular Subtypes in Papillary Thyroid Carcinoma.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

本研究利用癌症基因组图谱甲状腺癌研究数据,计算既往验证的10个单核苷酸变异多基因评分(PGS),纳入359例患者,采用多项逻辑回归分析PGS与基于驱动突变状态定义的分子亚型的关联。结果显示PGS与BRAFV600E突变型甲状腺乳头状癌风险升高相关,但与RAS突变型相比无显著差异;探索性分析中PGS也与基于mRNA、microRNA和DNA甲基化定义的分子亚型相关。

要点

  • PGS与BRAFV600E突变型甲状腺乳头状癌风险升高相关。
  • PGS在RAS突变型与BRAFV600E突变型之间无显著差异。
  • PGS与基于mRNA、microRNA和DNA甲基化定义的分子亚型也相关。

核心结论

  • PGS在甲状腺乳头状癌中具有分子亚型特异性关联,对其用于风险预测具有意义。

研究设计与样本

  • 本研究利用癌症基因组图谱甲状腺癌研究数据,纳入359例患者,计算既往验证的10个单核苷酸变异多基因评分,采用多项逻辑回归分析PGS与分子亚型的关联,并估计OR及95%CI。

主要发现

  • 在359例患者中,PGS与基于肿瘤驱动突变状态定义的特定分子亚型显著相关。
  • 生殖系风险增加与BRAFV600E突变型甲状腺乳头状癌相比「其他」类别无驱动突变者的风险升高相关。
  • RAS亚型与BRAFV600E亚型相比,PGS在肿瘤分类方面未检测到显著差异。
  • 探索性分析中,PGS也与癌症基因组图谱甲状腺乳头状癌研究定义的mRNA、microRNA和DNA甲基化分子亚型相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Genome-wide association studies have identified germline variants associated with elevated PTC risk. It is also known that somatic driver mutations contribute to PTC development and as such PTCs can be further categorized into different molecular subtypes based on their somatic alterations. However, it remains unknown whether identified germline variants predictive of PTC risk are associated with specific molecular subtypes. OBJECTIVE: The primary goal of the present study is to determine whether germline genetic risk, as assessed using a polygenic score (PGS) is associated with molecular subtypes of papillary thyroid carcinoma (PTC), defined based on tumor driver mutation status. METHODS: This study was carried out using data from The Cancer Genome Atlas (TCGA) thyroid cancer study. A previously validated 10-single-nucleotide variation PGS for PTC derived from genome-wide association study hits was calculated to ascertain germline genetic risk. The primary molecular subtypes of interest were defined by tumor driver mutation status (BRAFV600E-mutated vs RAS-mutated vs "other"). We also explored associations between PGS and molecular subtypes defined by messenger RNA (mRNA) expression, microRNA expression, and DNA methylation patterns. Polytomous logistic regression analysis was used to assess the association between PGS and PTC molecular subtype with and without adjustment for clinical variables. Odds ratios (ORs) with their 95% CIs were estimated. RESULTS: A total of 359 patients were included in the study. PGS was significantly associated specific tumor molecular subtypes defined by tumor driver mutation status. Increasing germline risk was associated with having a higher odd of BRAFV600E-mutated PTC compared to PTCs without driver mutations in the "other" category. No significant difference was detected in terms of PGS tumor categorization in the RAS subtype compared to BRAFV600E. In exploratory analyses, PGS was also associated with mRNA-, microRNA-, and DNA methylation-defined molecular subtypes, as defined by the TCGA PTC study. CONCLUSION: PGS has molecular subtype-specific associations in PTC, which has implications for their use in risk prediction.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Wang JR, Zafereo ME, Wang W, et al. Association of Polygenic Score With Tumor Molecular Subtypes in Papillary Thyroid Carcinoma. J Clin Endocrinol Metab. 2023. PMID: 37453101. doi:10.1210/clinem/dgad407

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。